{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T00:29:33Z","timestamp":1794529773595,"version":"4.9.1"},"reference-count":137,"publisher":"Elsevier BV","issue":"10-11","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.clinbiochem.2009.04.001","type":"journal-article","created":{"date-parts":[[2009,4,11]],"date-time":"2009-04-11T04:11:39Z","timestamp":1239423099000},"page":"929-942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":156,"title":["Bone turnover markers in the management of postmenopausal osteoporosis"],"prefix":"10.1016","volume":"42","author":[{"given":"Jacques P.","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassam A.","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Shawn","family":"Davison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent C.","family":"Dooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Don-Wauchope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Douville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie A.","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Josse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Lepage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Letendre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daylily S.","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Papaioaonnou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Georges","family":"Ste-Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2009.04.001_bib1","first-page":"S1","article-title":"2002 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada","volume":"167","author":"Brown","year":"2002","journal-title":"CMAJ"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib2","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00198-008-0712-1","article-title":"Case finding for the management of osteoporosis with FRAX\u2014assessment and intervention thresholds for the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s001980200068","article-title":"Biochemical indices of bone turnover and the assessment of fracture probability","volume":"13","author":"Johnell","year":"2002","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib4","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1359\/JBMR.050609","article-title":"Identification of osteopenic women at high risk of fracture: the OFELY study","volume":"20","author":"Sornay-Rendu","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S8756-3282(00)00325-2","article-title":"Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS study","volume":"27","author":"Chapurlat","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib6","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jbmr.5650111021","article-title":"Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study","volume":"11","author":"Garnero","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s001980050009","article-title":"Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study","volume":"11","author":"Ross","year":"2000","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF03256280","article-title":"Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring","volume":"12","author":"Garnero","year":"2008","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jbmr.5650110307","article-title":"Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis","volume":"11","author":"Garnero","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/8756-3282(93)90092-O","article-title":"Age- and sex-related changes in iliac cortical bone mass and remodeling","volume":"14","author":"Brockstedt","year":"1993","journal-title":"Bone"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib11","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.beem.2008.07.006","article-title":"Bone remodelling: its local regulation and the emergence of bone fragility","volume":"22","author":"Martin","year":"2008","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00223-001-2048-0","article-title":"The degree of mineralization of bone tissue measured by computerized quantitative contact microradiography","volume":"70","author":"Boivin","year":"2002","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib13","doi-asserted-by":"crossref","first-page":"e2942","DOI":"10.1371\/journal.pone.0002942","article-title":"Control of bone mass and remodeling by PTH receptor signaling in osteocytes","volume":"3","author":"O'Brien","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib14","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.bone.2008.01.030","article-title":"Osteocyte morphology in fibula and calvaria \u2014 is there a role for mechanosensing?","volume":"43","author":"Vatsa","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib15","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/clinchem\/45.10.1858","article-title":"Diurnal rhythm of CrossLaps in human serum","volume":"45","author":"Wichers","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s002239900497","article-title":"Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment","volume":"63","author":"Gertz","year":"1998","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/gme.0b013e31815f8917","article-title":"Bone turnover marker profile in relation to the menstrual cycle of premenopausal healthy women","volume":"15","author":"Gass","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1024\/0300-9831.77.5.320","article-title":"Seasonal changes in vitamin D status and bone turnover in healthy Irish postmenopausal women","volume":"77","author":"Hill","year":"2007","journal-title":"Int. J. Vitam. Nutr. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib19","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1359\/JBMR.040511","article-title":"Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial","volume":"19","author":"Meier","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib20","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.bone.2008.01.011","article-title":"Vitamin D status in postmenopausal women living at higher latitudes in the UK in relation to bone health, overweight, sunlight exposure and dietary vitamin D","volume":"42","author":"Macdonald","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib21","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1359\/jbmr.1999.14.10.1664","article-title":"Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development","volume":"14","author":"Mora","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2265.1994.tb03019.x","article-title":"Biochemical markers of bone turnover in girls during puberty","volume":"40","author":"Blumsohn","year":"1994","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib23","first-page":"1522","article-title":"Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study","volume":"82","author":"Khosla","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1203\/00006450-198703000-00020","article-title":"Clearance of osteocalcin by peritoneal dialysis in children with end-stage renal disease","volume":"21","author":"Gundberg","year":"1987","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib25","first-page":"3289","article-title":"Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease","volume":"81","author":"Seibel","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF02508639","article-title":"The effects of brisk walking on markers of bone and calcium metabolism in postmenopausal women","volume":"58","author":"Thorsen","year":"1996","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib27","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1359\/jbmr.1998.13.12.1797","article-title":"Changes in bone turnover induced by aerobic and anaerobic exercise in young males","volume":"13","author":"Woitge","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib28","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1359\/jbmr.1998.13.10.1594","article-title":"The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects","volume":"13","author":"Zerwekh","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s001980050246","article-title":"Changes in bone mass and bone turnover following distal forearm fracture","volume":"10","author":"Ingle","year":"1999","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0009-8981(95)06125-0","article-title":"The stability of pyridinium crosslinks in urine and serum","volume":"240","author":"Walne","year":"1995","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/clinchem\/41.4.571","article-title":"Determination of pyridinoline and deoxypyridinoline in urine, with special attention to retaining their stability","volume":"41","author":"Gerrits","year":"1995","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib32","first-page":"841","article-title":"Effect of different storage temperatures, sample collection procedures and immunoassay methods on osteocalcin measurement","volume":"34","author":"Noonan","year":"1996","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib33","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/clinchem\/47.4.694","article-title":"Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis","volume":"47","author":"Garnero","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-0029-1211967","article-title":"Automated and manual assays for urinary crosslinks of collagen: which assay to use?","volume":"106","author":"Seibel","year":"1998","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/00365519950185229","article-title":"Current databases on biological variation: pros, cons and progress","volume":"59","author":"Ricos","year":"1999","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bone.2007.12.218","article-title":"Establishing a reference range for bone turnover markers in young, healthy women","volume":"42","author":"Glover","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib37","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.bone.2007.01.008","article-title":"A cross-sectional study of bone turnover markers in healthy premenopausal women","volume":"40","author":"de Papp","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib38","unstructured":"Serum beta crosslaps product information. Roche Diagnostics, Basel, Switzerland."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib39","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1359\/jbmr.1998.13.7.1124","article-title":"Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability","volume":"13","author":"Hannon","year":"1998","journal-title":"J. Bone Miner. Res."},{"issue":"Pt 3","key":"10.1016\/j.clinbiochem.2009.04.001_bib40","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/000456329703400316","article-title":"Intra-individual variation in serum type I procollagen carboxy-terminal propeptide and type I collagen carboxy-terminal cross-linked telopeptide concentrations","volume":"34","author":"Stevenson","year":"1997","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib41","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1093\/clinchem\/44.11.2290","article-title":"Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides","volume":"44","author":"Christgau","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib42","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/clinchem\/47.8.1410","article-title":"Clinical evaluation of the Elecsys beta-CrossLaps serum assay, a new assay for degradation products of type I collagen C-tlopeptides","volume":"47","author":"Okabe","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cca.2008.03.020","article-title":"The amino- and carboxyterminal cross-linked telopeptides of collagen type I, NTX-I and CTX-I: A comparative review","volume":"393","author":"Herrmann","year":"2008","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib44","unstructured":"Serum crosslaps product information. Nordic Biosciences, Herlev, Denmark."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib45","unstructured":"VITROS NTX AI Product Information. Ortho-Clinical Diagnostics, Raritan, NJ."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib46","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/clinchem\/43.9.1570","article-title":"Comparison of analytical performance and biological variability of three bone resorption assays","volume":"43","author":"Ju","year":"1997","journal-title":"Clin. Chem."},{"issue":"Pt 4","key":"10.1016\/j.clinbiochem.2009.04.001_bib47","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/000456329603300411","article-title":"Intra-individual variation in bone resorption markers in urine","volume":"33","author":"Popp-Snijders","year":"1996","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib48","unstructured":"Osteomark NTX urine product information. Wampole Laboratories, Princeton, NJ."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib49","unstructured":"Ostase Product Information. Beckman Coulter Inc., Fullerton, CA."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib50","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/00365519509110260","article-title":"Biological variation in bone-derived biochemical markers in serum","volume":"55","author":"Panteghini","year":"1995","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib51","unstructured":"Metra BAP product information. Quidel Corporation Specialty Products, San Diego, CA."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib52","unstructured":"PINP Product Information. Roche Diagnostics, Basel, Switzerland."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib53","unstructured":"UniQ PINP RIA product information. Orion Diagnostica, Espoo, Finland."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib54","unstructured":"N-Mid Osteocalcin product information. Roche Diagnostics, Basel, Switzerland."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib55","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/00365519709099408","article-title":"A single measurement of biochemical markers of bone turnover has limited utility in the individual person","volume":"57","author":"Beck-Jensen","year":"1997","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib56","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/00365519409088575","article-title":"Biological variation of biochemical bone markers","volume":"219","author":"Jensen","year":"1994","journal-title":"Scand. J. Clin. Lab. Invest., Suppl."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib57","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1515\/CCLM.2004.017","article-title":"Performance evaluation of automated assays for beta-CrossLaps, N-MID-Osteocalcin and intact parathyroid hormone (BIOROSE Multicenter Study)","volume":"42","author":"Schmidt-Gayk","year":"2004","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib58","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0009-8981(99)00251-X","article-title":"Comparison of the analytical and clinical performance characteristics of an N-MID versus an intact osteocalcin immunoradiometric assay","volume":"294","author":"Takahashi","year":"2000","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib59","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00198-004-1634-1","article-title":"Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) Study","volume":"15","author":"Iki","year":"2004","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib60","first-page":"31","article-title":"Validation of a new automated immunoassay for measurement of intact osteocalcin","volume":"48","author":"Fassbender","year":"2002","journal-title":"Clin. Lab."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib61","first-page":"499","article-title":"Serum vitamin D, parathyroid hormone and biochemical markers of bone turnover in normal Thai subjects","volume":"79","author":"Chailurkit","year":"1996","journal-title":"J. Med. Assoc. Thai."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib62","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00774-006-0703-2","article-title":"Age-related changes in bone biochemical markers and their relationship with bone mineral density in normal Chinese women","volume":"24","author":"Pi","year":"2006","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib63","first-page":"170","article-title":"A cross-sectional study on biochemical parameters of bone turnover and vitamin d metabolites in healthy Dutch children and young adults","volume":"57","author":"van der Sluis","year":"2002","journal-title":"Horm. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib64","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.clinbiochem.2005.11.015","article-title":"Pediatric reference intervals for bone markers","volume":"39","author":"Yang","year":"2006","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib65","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/jc.2006-1706","article-title":"Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2\u00a0months to 18\u00a0years","volume":"92","author":"Rauchenzauner","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib66","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-008-0560-z","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib67","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1742-1241.2008.01911.x","article-title":"Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club","volume":"63","author":"Bergmann","year":"2009","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib68","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/10408360801949442","article-title":"Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis","volume":"45","author":"Vasikaran","year":"2008","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib69","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/jcp.2007.047175","article-title":"What is a significant difference between sequential laboratory results?","volume":"61","author":"Smellie","year":"2008","journal-title":"J. Clin. Pathol."},{"issue":"Suppl 6","key":"10.1016\/j.clinbiochem.2009.04.001_bib70","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1007\/s001980070002","article-title":"The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation","volume":"11","author":"Delmas","year":"2000","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib71","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/clinchem\/39.7.1447","article-title":"Desirable standards for laboratory tests if they are to fulfil clinical needs","volume":"39","author":"Fraser","year":"1993","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib72","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00223-008-9126-5","article-title":"Determinants of bone turnover markers in healthy premenopausal women","volume":"82","author":"Adami","year":"2008","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib73","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1359\/JBMR.040512","article-title":"Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial","volume":"19","author":"Bauer","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib74","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1359\/jbmr.2003.18.6.1051","article-title":"Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate","volume":"18","author":"Eastell","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib75","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.bone.2006.06.007","article-title":"Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis","volume":"39","author":"Gallagher","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib76","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1185\/030079905X75096","article-title":"Development of an algorithm for using PINP to monitor treatment of patients with teriparatide","volume":"22","author":"Eastell","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"issue":"Pt 4","key":"10.1016\/j.clinbiochem.2009.04.001_bib77","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1177\/000456320003700402","article-title":"Measurement of osteocalcin","volume":"37","author":"Lee","year":"2000","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib78","series-title":"Calcium regulation and bone metabolism: basic and clinical aspects","first-page":"419","article-title":"Vitamin K-dependent proteins","author":"Price","year":"1987"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib79","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/8756-3282(85)90326-6","article-title":"Serum bone Gla-protein compared to bone histomorphometry in endocrine diseases","volume":"6","author":"Delmas","year":"1985","journal-title":"Bone"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib80","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1172\/JCI112234","article-title":"Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion","volume":"76","author":"Charles","year":"1985","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib81","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1359\/jbmr.1997.12.3.447","article-title":"Identification of peptide fragments generated by digestion of bovine and human osteocalcin with the lysosomal proteinases cathepsin B, D, L, H, and S","volume":"12","author":"Baumgrass","year":"1997","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib82","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0020-711X(93)90662-X","article-title":"Degradation of bone matrix proteins by osteoclast cathepsins","volume":"25","author":"Page","year":"1993","journal-title":"Int. J. Biochem."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib83","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jbmr.5650050104","article-title":"Bone Gla protein (osteocalcin) assay standardization report","volume":"5","author":"Delmas","year":"1990","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib84","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1530\/eje.0.1400332","article-title":"Acute fasting diminishes the circadian rhythm of biochemical markers of bone resorption","volume":"140","author":"Schlemmer","year":"1999","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib85","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/clinchem\/31.10.1720","article-title":"Determination of osteocalcin in human serum: results with two kits compared with those by a well-characterized assay","volume":"31","author":"Gundberg","year":"1985","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib86","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/clinchem\/40.11.2071","article-title":"Six osteocalcin assays compared","volume":"40","author":"Diaz Diego","year":"1994","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib87","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/clinchem\/41.2.318","article-title":"Apparent instability of osteocalcin in serum as measured with different commercially available immunoassays","volume":"41","author":"Blumsohn","year":"1995","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib88","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1210\/jc.2005-1712","article-title":"Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis","volume":"91","author":"Bauer","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib89","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1373\/clinchem.2007.094953","article-title":"Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis","volume":"54","author":"Garnero","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib90","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1210\/jc.2005-2602","article-title":"Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years","volume":"91","author":"Bonnick","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib91","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bone.2003.10.004","article-title":"Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk","volume":"34","author":"Reginster","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib92","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1359\/JBMR.050105","article-title":"Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis","volume":"20","author":"Chen","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib93","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis","volume":"349","author":"Black","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib94","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/clinchem\/46.8.1200","article-title":"Stability of several biochemical markers of bone metabolism","volume":"46","author":"Lomeo","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib95","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S8756-3282(02)00728-7","article-title":"Effect of feeding on bone turnover markers and its impact on biological variability of measurements","volume":"30","author":"Clowes","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib96","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1084\/jem.179.2.405","article-title":"Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells","volume":"179","author":"Melkko","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib97","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/bjc.1998.471","article-title":"Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients","volume":"78","author":"Saarto","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib98","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1359\/jbmr.1999.14.9.1614","article-title":"Markers of bone turnover predict postmenopausal forearm bone loss over 4\u00a0years: the OFELY study","volume":"14","author":"Garnero","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib99","series-title":"Alkaline phosphatase","author":"McComb","year":"1979"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib100","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000067254","article-title":"Monoclonal antibodies against tissue-nonspecific alkaline phosphatase. Report of the ISOBM TD9 workshop","volume":"23","author":"Magnusson","year":"2002","journal-title":"Tumour Biol."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib101","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1359\/JBMR.040920","article-title":"Treatment with once-weekly alendronate 70\u00a0mg compared with once-weekly risedronate 35\u00a0mg in women with postmenopausal osteoporosis: a randomized double-blind study","volume":"20","author":"Rosen","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib102","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s002239900451","article-title":"Differences in bone resorption after menopause in Japanese women with normal or low bone mineral density: quantitation of urinary cross-linked N-telopeptides","volume":"62","author":"Taguchi","year":"1998","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib103","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0378-5122(01)00248-1","article-title":"Bone metabolism during the perimenopausal transition: a prospective study","volume":"41","author":"Seifert-Klauss","year":"2002","journal-title":"Maturitas"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib104","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1359\/jbmr.2000.15.3.594","article-title":"Biological variability of serum and urinary N-telopeptides of type I collagen in postmenopausal women","volume":"15","author":"Eastell","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib105","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1359\/jbmr.2000.15.8.1526","article-title":"Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study","volume":"15","author":"Garnero","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib106","first-page":"97","article-title":"Biochemical markers of bone turnover: part I: biochemistry and variability","volume":"26","author":"Seibel","year":"2005","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib107","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/clinchem\/42.10.1639","article-title":"Coated-tube radioimmunoassay for C-telopeptides of type I collagen to assess bone resorption","volume":"42","author":"Bonde","year":"1996","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib108","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1093\/clinchem\/40.11.2022","article-title":"Immunoassay for quantifying type I collagen degradation products in urine evaluated","volume":"40","author":"Bonde","year":"1994","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib109","doi-asserted-by":"crossref","first-page":"9755","DOI":"10.1074\/jbc.272.15.9755","article-title":"Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha1) region","volume":"272","author":"Fledelius","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"Pt 3","key":"10.1016\/j.clinbiochem.2009.04.001_bib110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1042\/bj3450473","article-title":"Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential","volume":"345","author":"Cloos","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib111","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib112","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/clinchem\/46.3.431a","article-title":"Circadian variation in serum CrossLaps concentration is reduced in fasting individuals","volume":"46","author":"Christgau","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib113","first-page":"123","article-title":"Biochemical markers of bone turnover part II: clinical applications in the management of osteoporosis","volume":"27","author":"Seibel","year":"2006","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib114","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0009-8981(79)90200-6","article-title":"The clinical measurement of urinary total hydroxyproline excretion","volume":"95","author":"Gasser","year":"1979","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib115","first-page":"2447","article-title":"Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients","volume":"80","author":"Kushida","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib116","first-page":"2266","article-title":"Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen","volume":"83","author":"Khosla","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib117","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/8756-3282(87)90002-0","article-title":"Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women","volume":"8","author":"Stepan","year":"1987","journal-title":"Bone"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib118","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/jbmr.5650090916","article-title":"Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: results of a pilot study","volume":"9","author":"Seibel","year":"1994","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib119","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1359\/jbmr.1998.13.2.297","article-title":"Rapid bone loss is associated with increased levels of biochemical markers","volume":"13","author":"Ross","year":"1998","journal-title":"J. Bone Miner. Res."},{"issue":"Suppl 6","key":"10.1016\/j.clinbiochem.2009.04.001_bib120","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1007\/s001980070006","article-title":"Markers of bone turnover for the prediction of fracture risk","volume":"11","author":"Garnero","year":"2000","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib121","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00198-004-1661-y","article-title":"Risk factors for hip fracture in women with high BMD: EPIDOS study","volume":"16","author":"Robbins","year":"2005","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib122","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archinte.164.10.1108","article-title":"Bone mineral density thresholds for pharmacological intervention to prevent fractures","volume":"164","author":"Siris","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib123","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1172\/JCI113725","article-title":"Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment","volume":"82","author":"Civitelli","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib124","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s002239900713","article-title":"Bone turnover and the response to alendronate treatment in postmenopausal osteoporosis","volume":"65","author":"Gonnelli","year":"1999","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib125","first-page":"1904","article-title":"The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation","volume":"82","author":"Rosen","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib126","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.bone.2008.01.021","article-title":"Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapy","volume":"42","author":"Reginster","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib127","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1359\/JBMR.0301231","article-title":"Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate","volume":"19","author":"Seibel","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib128","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s001980170020","article-title":"Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3\u00a0years of raloxifene treatment in postmenopausal osteoporosis","volume":"12","author":"Bjarnason","year":"2001","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib129","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.2165\/00003495-200666160-00001","article-title":"Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls","volume":"66","author":"Cremers","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib130","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1359\/JBMR.0301243","article-title":"Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk","volume":"19","author":"Sarkar","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib131","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2003-1703","article-title":"Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy","volume":"90","author":"Dobnig","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib132","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1210\/jc.2006-1856","article-title":"Discontinuation of antiresorptive therapies: a comparison between 1998\u20132001 and 2002\u20132004 among osteoporotic women","volume":"92","author":"Blouin","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib133","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2125.2008.03178.x","article-title":"Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women","volume":"66","author":"Blouin","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib134","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4065\/81.8.1013","article-title":"Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases","volume":"81","author":"Siris","year":"2006","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib135","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s001980200101","article-title":"Does follow-up of osteoporotic women treated with antiresorptive therapies improve effectiveness?","volume":"13","author":"Chapurlat","year":"2002","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib136","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1210\/jc.2003-030501","article-title":"The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial","volume":"89","author":"Clowes","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2009.04.001_bib137","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1210\/jc.2006-1526","article-title":"Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis","volume":"92","author":"Delmas","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912009001817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912009001817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:32:09Z","timestamp":1757863929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912009001817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":137,"journal-issue":{"issue":"10-11","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0009912009001817"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.04.001","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone turnover markers in the management of postmenopausal osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}